1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
- 5.1 Global Systemic Mastocytosis Treatment Market 2018 - 2022
- Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2018 - 2022 ($ million)
- 5.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 5.3 Route of Administration segment analysis 2018 - 2022
- Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
- 5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on the Global Systemic Mastocytosis Treatment Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 AK-002 - Market size and forecast 2023-2028
- Chart on AK-002 - Market size and forecast 2023-2028 ($ million)
- Data Table on AK-002 - Market size and forecast 2023-2028 ($ million)
- Chart on AK-002 - Year-over-year growth 2023-2028 (%)
- Data Table on AK-002 - Year-over-year growth 2023-2028 (%)
- 8.4 BLU-285 - Market size and forecast 2023-2028
- Chart on BLU-285 - Market size and forecast 2023-2028 ($ million)
- Data Table on BLU-285 - Market size and forecast 2023-2028 ($ million)
- Chart on BLU-285 - Year-over-year growth 2023-2028 (%)
- Data Table on BLU-285 - Year-over-year growth 2023-2028 (%)
- 8.5 Brentuximab vedotin - Market size and forecast 2023-2028
- Chart on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
- Data Table on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
- Chart on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
- Data Table on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
- 8.6 Crenolanib besylate - Market size and forecast 2023-2028
- Chart on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
- Data Table on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
- Chart on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
- Data Table on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
- 8.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 8.8 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Route of Administration
- 9.1 Market segments
- Chart on Route of Administration - Market share 2023-2028 (%)
- Data Table on Route of Administration - Market share 2023-2028 (%)
- 9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 9.3 Oral - Market size and forecast 2023-2028
- Chart on Oral - Market size and forecast 2023-2028 ($ million)
- Data Table on Oral - Market size and forecast 2023-2028 ($ million)
- Chart on Oral - Year-over-year growth 2023-2028 (%)
- Data Table on Oral - Year-over-year growth 2023-2028 (%)
- 9.4 Injectables - Market size and forecast 2023-2028
- Chart on Injectables - Market size and forecast 2023-2028 ($ million)
- Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
- Chart on Injectables - Year-over-year growth 2023-2028 (%)
- Data Table on Injectables - Year-over-year growth 2023-2028 (%)
- 9.5 Topical - Market size and forecast 2023-2028
- Chart on Topical - Market size and forecast 2023-2028 ($ million)
- Data Table on Topical - Market size and forecast 2023-2028 ($ million)
- Chart on Topical - Year-over-year growth 2023-2028 (%)
- Data Table on Topical - Year-over-year growth 2023-2028 (%)
- 9.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 11.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 11.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 11.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 11.12 Spain - Market size and forecast 2023-2028
- Chart on Spain - Market size and forecast 2023-2028 ($ million)
- Data Table on Spain - Market size and forecast 2023-2028 ($ million)
- Chart on Spain - Year-over-year growth 2023-2028 (%)
- Data Table on Spain - Year-over-year growth 2023-2028 (%)
- 11.13 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 11.14 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 11.15 South Korea - Market size and forecast 2023-2028
- Chart on South Korea - Market size and forecast 2023-2028 ($ million)
- Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
- Chart on South Korea - Year-over-year growth 2023-2028 (%)
- Data Table on South Korea - Year-over-year growth 2023-2028 (%)
- 11.16 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 A. Menarini Industrie Farmaceutiche Riunite Srl
- A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
- A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
- A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
- SWOT
- 14.5 Blueprint Medicines Corp.
- Blueprint Medicines Corp. - Overview
- Blueprint Medicines Corp. - Product / Service
- Blueprint Medicines Corp. - Key news
- Blueprint Medicines Corp. - Key offerings
- SWOT
- 14.6 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- 14.7 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 14.8 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
- 14.9 Intas Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
- SWOT
- 14.10 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- 14.11 NOVA PHARMA LLC
- NOVA PHARMA LLC - Overview
- NOVA PHARMA LLC - Product / Service
- NOVA PHARMA LLC - Key offerings
- SWOT
- 14.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 14.13 Ono Pharmaceutical Co. Ltd.
- Ono Pharmaceutical Co. Ltd. - Overview
- Ono Pharmaceutical Co. Ltd. - Product / Service
- Ono Pharmaceutical Co. Ltd. - Key offerings
- SWOT
- 14.14 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 14.15 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- 14.16 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
- 14.17 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT
- 14.18 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
15 Appendix
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations